Items tagged with Access
Increasing shortages of medicines discussed at WHO, to be continued in May (post)
There is an increasing shortage of medicines in the world, in particular in developing countries, but not only there, World Health Organization members said in last week’s Executive Board meeting. Discussions are ongoing on potential solutions and the agenda item referring to the issue was left open, to be brought to the World Health Assembly in May.
WHO still on trail of new financing for R&D for poor populations’ medical needs (post)
World Health Organization members are expected to meet this spring to assess progress and discuss potential solutions to the lack of financing for research and development for diseases affecting primarily developing countries.
Bedaquiline, new pill to treat MDR-TB, to arrive in India soon (post)
CHENNAI, February 7, 2016: Bedaquiline, a new drug to treat extensively drug-resistant tuberculosis (XDR-TB), will soon be introduced in government facilities at selected centres across the country, according to the Indian Council of Medical Research (ICMR).
UNSG's High-Level Panel on Access to Medicines extends deadline for contributions (post)
Following feedback from several partners, the United Nations Secretary-General's High-Level Panel on Access to Medicines has extended the submission deadline for contributions until 28 February 2016, 11 P.M. Eastern Standard Time.
MSF statement on a donation of TB drugs from Otsuka Pharmaceuticals (post)
19 February 2016 - MSF appreciates Otsuka Pharmaceuticals’ donation of 400 treatments of a novel drug, delamanid, which enables MSF and its partners to initially treat a specific number of MDR-TB patients worldwide.
Global introduction of new multidrug-resistant tuberculosis drugs—balancing regulation with urgent patient needs (post)
Abstract
Trans-Pacific Partnership provisions in intellectual property, transparency, and investment chapters threaten access to medicines in the US and elsewhere (post)
Summary points
WHO welcomes UN Secretary-General’s High-Level Panel on Access to Medicines, offers suggestions (post)
The World Health Organization has provided a list of suggestions to the United Nations Secretary General’s High-Level Panel on Access to Medicines, highlighting WHO activities in this area and making suggestions on areas the WHO has not yet been able to complete. It also describes several new proposals by WHO, including a global “fair pricing forum,” a pooled health product R&D fund, and a global antibiotic research and development facility.
High-level UN initiative on global public health gap holds landmark hearing (post)
An initiative of the United Nations secretary general yesterday gathered what could be described as an assembly of many of the world’s best thinkers and practitioners on public health and intellectual property rights. Industry, activists, academics, international organisations, and possibly some governments poured out their views for nearly seven hours – at times coming to tears and tension – shepherded by an astute moderator, as they responded to the call to take a longstanding debate on medicines access and high prices to a breakthrough.
North Korean tuberculosis patients at risk as sanctions hamper medicine shipments (post)
TOKYO, March 9, 2016 — The lives of more than 1,500 North Korean tuberculosis patients are at risk, an American-run humanitarian foundation said Wednesday, because tough new sanctions are stopping medicine from getting to sick people.
Page 18 of 83 · Total posts: 0
←First 17 18 19 Last→